| Accession |
PRJCA002482 |
| Title |
The genomic characteristics of ALK fusion positive tumors in Chinese NSCLC patients |
| Relevance |
Medical |
| Data types |
Raw sequence reads
Genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
Anaplastic lymphoma kinase (ALK) fusion events account for approximately 3-7% genetic alterations in non-small cell lung cancer (NSCLC) patients. In this study, we identified the ALK fusion patterns and a novel ALK fusion partner in 44 ALK positive NSCLC patients using a customized HapOncoCDx panel, and identified ALK fusion partners. Together, these results may guide personalized clinical management of patients with ALK fusion in the era of precision medicine. |
| Sample scope |
Multiisolate |
| Release date |
2020-04-03 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
| 32457845
|
The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients
|
Frontiers in Oncology
|
10.3389/fonc.2020.00726
|
2020
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Shenzhen Science and Technology Innovation Committee Technical Research Project
|
|
JSGG20180703164202084
|
|
| National Key Clinical Specialty Construction Projects of China
|
|
2012650
|
|
| Development and Reform Commission of Shenzhen Municipality
|
|
XMHT20190104006
|
|
| Bureau of Industry and Information Technology of Shenzhen
|
|
20170922151538732
|
|
|
|
| Submitter |
Shifu
Chen (chen@haplox.com)
|
| Organization |
HaploX Biotechnology Co., Ltd |
| Submission date |
2020-04-03 |
